248 related articles for article (PubMed ID: 19997092)
21. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?
Horváth G; Farkas K; Hollósi R; Nagy F; Szepes Z; Papp M; Palatka K; Miheller P; Lakatos L; Szamosi T; Nyári T; Wittmann T; Molnár T
Scand J Gastroenterol; 2012 Nov; 47(11):1298-303. PubMed ID: 22935014
[TBL] [Abstract][Full Text] [Related]
22. Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study.
Hall NJ; Rubin GP; Hungin AP; Dougall A
BMC Gastroenterol; 2007 Jun; 7():20. PubMed ID: 17559670
[TBL] [Abstract][Full Text] [Related]
23. Clustering patients according to health perceptions: relationships to psychosocial characteristics and medication nonadherence.
Sewitch MJ; Leffondré K; Dobkin PL
J Psychosom Res; 2004 Mar; 56(3):323-32. PubMed ID: 15046970
[TBL] [Abstract][Full Text] [Related]
24. Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease.
Thomason MM; Poulopoulos N; Nguyen E; Gumidyala AP; Kahn SA; Greenley RN
J Child Health Care; 2017 Sep; 21(3):253-262. PubMed ID: 29119807
[TBL] [Abstract][Full Text] [Related]
25. Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.
Fu N; Jacobson K; Round A; Evans K; Qian H; Bressler B
World J Gastroenterol; 2017 Aug; 23(29):5405-5411. PubMed ID: 28839441
[TBL] [Abstract][Full Text] [Related]
26. Oral medication adherence and disease severity in pediatric inflammatory bowel disease.
Hommel KA; Denson LA; Baldassano RN
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):250-4. PubMed ID: 21304318
[TBL] [Abstract][Full Text] [Related]
27. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
[TBL] [Abstract][Full Text] [Related]
28. Adherence to medical treatment in inflammatory bowel disease patients.
Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
[TBL] [Abstract][Full Text] [Related]
29. A Pilot Study Evaluating the Impact of an Adherence-promoting Intervention Among Nonadherent Youth With Inflammatory Bowel Disease.
Maddux M; Ricks S; Delurgio S; Hommel K
J Pediatr Nurs; 2017; 35():72-77. PubMed ID: 28728772
[TBL] [Abstract][Full Text] [Related]
30. Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease.
Moradkhani A; Kerwin L; Dudley-Brown S; Tabibian JH
Dig Dis Sci; 2011 Oct; 56(10):2972-7. PubMed ID: 21538016
[TBL] [Abstract][Full Text] [Related]
31. Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
Targownik LE; Tennakoon A; Leung S; Lix LM; Nugent Z; Singh H; Bernstein CN
Inflamm Bowel Dis; 2017 Mar; 23(3):409-420. PubMed ID: 28221250
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
Campos S; Portela F; Sousa P; Sofia C
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
[TBL] [Abstract][Full Text] [Related]
33. [Treatment adherence in inflammatory bowel disease. Strategies for improvement].
Bermejo San José F; López San Román A; García AA
Gastroenterol Hepatol; 2009 Oct; 32 Suppl 2():31-6. PubMed ID: 19900626
[TBL] [Abstract][Full Text] [Related]
34. Medication-Related Knowledge and Medication Adherence in Pediatric and Adolescent Patients with Inflammatory Bowel Disease.
Lim JK; Lee YJ; Park JH
J Korean Med Sci; 2020 Apr; 35(14):e92. PubMed ID: 32281312
[TBL] [Abstract][Full Text] [Related]
35. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
[TBL] [Abstract][Full Text] [Related]
36. Psychosocial correlates of patient-physician discordance in inflammatory bowel disease.
Sewitch MJ; Abrahamowicz M; Bitton A; Daly D; Wild GE; Cohen A; Katz S; Szego PL; Dobkin PL
Am J Gastroenterol; 2002 Sep; 97(9):2174-83. PubMed ID: 12358229
[TBL] [Abstract][Full Text] [Related]
37. Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review.
Depont F; Berenbaum F; Filippi J; Le Maitre M; Nataf H; Paul C; Peyrin-Biroulet L; Thibout E
PLoS One; 2015; 10(12):e0145076. PubMed ID: 26674526
[TBL] [Abstract][Full Text] [Related]
38. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
McHorney CA; Schousboe JT; Cline RR; Weiss TW
Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
[TBL] [Abstract][Full Text] [Related]
39. Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review.
Khan S; Rupniewska E; Neighbors M; Singer D; Chiarappa J; Obando C
J Clin Pharm Ther; 2019 Aug; 44(4):495-507. PubMed ID: 30873648
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
